Alyeska Investment Group »

Humacyte shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.7M 6.0M 0.78

More positions owned by Alyeska Investment Group

Ishares Tr Core S&p500 Etf (IVV)
Coreweave Com Cl A (CRWV)
Meta Platforms Cl A (META)
salesforce (CRM)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Intuitive Surgical Com New (ISRG)
Amazon (AMZN)
Amphenol Corp Cl A (APH)
Gpgi Com Cl A (GPGI)
Spotify Technology S A SHS (SPOT)
Analog Devices (ADI)
Burlington Stores (BURL)
Zebra Technologies Corporati Cl A (ZBRA)
Merck & Co (MRK)

View all positions for Alyeska Investment Group

Top funds holding Humacyte

Vanguard Capital Management
Antipodes Partners
Alyeska Investment Group
Davidson Kempner Capital Management
BlackRock
Dr. Jeffrey R. Jay, M.D.
State Street Corporation
Susquehanna International
UBS Group
AQR Capital Management
Geode Capital Management
Millennium Management
Citadel Advisors
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Humacyte